A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum

Journal of Immunological Methods

Volumn 345, Issue 1-2, 2009, Pages 70-79

  Hu, Jenny ^a   Gupta, Shalini ^a   Swanson, Steve J ^a   Zhuang, Yao ^a  

^a AMGEN INC   (United States)

Author keywords

Biologically active drug concentration; Immunogenicity; Neutralizing antibodies

Indexed keywords

NEUTRALIZING ANTIBODY; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANTIBODY DETECTION; ARTICLE; BIOASSAY; BLOOD SAMPLING; CELL LYSATE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTIBODIES, MONOCLONAL; BIOLOGICAL ASSAY; BIOLOGICAL AVAILABILITY; CELL LINE; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; NEUTRALIZATION TESTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; RECOVERIN;

EID: 65649116948     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.04.005     Document Type: Article

References (7)

1. Gupta S., Indelicato S.R., Jethwa V., Kawabata T., Kelley M., Anthony R., Mire-Sluis A.R., Richards S.M., Rup B., Shores E., Swanson S.J., and Wakshull E. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics. J. Immunol. Methods 321 (2007) 1
2. Lofgren J.A., Wala I., Koren E., Swanson S.J., and Jing S. Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein. J. Immunol. Methods 308 (2006) 101
3. Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P., and Salgia R. Cytokine and Growth Factor Rev. 13 (2002) 41
4. Mire-Sluis A.R., Barrett Y.C., Devanarayan V., Koren E., Liu H., Maia M., Parish T., Scott G., Shankar G., Shores E., Swanson S., Tankguchi G., Wierda D., and Zuckerman L.A. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J. Immunol. Methods 289 (2004) 1
5. Patton A., Mullenix M.C., Swanson S.J., and Koren E. An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen. J. Immunol. Methods 304 (2005) 189
6. Schellekens H. The immunogenicity of biopharmaceuticals. Neurology 61 (2003) S11
7. Tarundeep K., Ma M., Zhuang Y., Patton A., Hu Z., and Mounho B. Pharmacokinetics and safety of a fully human hepatocyte growth factor antibody, AMG 102, in cynomolgus monkeys. Pharm. Res. 24 (2007) 1910